Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bluebird bio, Inc.    BLUE

BLUEBIRD BIO, INC.

(BLUE)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about BLUEBIRD BIO, INC.
11/24BLUEBIRD BIO : Announces Live Webcast to Review Clinical Data Presented at the A..
BU
11/19BLUEBIRD BIO : Corporate Presentation - November 2020
PU
11/10SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
11/10BLUEBIRD BIO : Announces November Investor Events
BU
11/05BLUEBIRD BIO : to Present Data from Gene and Cell Therapy Programs During the 62..
BU
11/04BLUEBIRD : 3Q Earnings Snapshot
AQ
11/04BLUEBIRD BIO : Reports Third Quarter 2020 Financial Results and Highlights Opera..
BU
10/02BLUEBIRD BIO : Announces European Medicines Agency's Acceptance of Marketing Aut..
BU
09/28BLUEBIRD BIO : Corporate Presentation - September 2020
PU
09/28BLUEBIRD BIO : to Present at Jefferies Cell Therapy Virtual Summit
BU
09/23BLUEBIRD BIO : LentiGlobin™ for Sickle Cell Disease Gene Therapy (bb1111) ..
BU
09/02BLUEBIRD BIO : Announces September Investor Events
BU
08/29BLUEBIRD BIO : Presents New Results from Clinical Development Program of elivald..
BU
08/18BLUEBIRD BIO : Corporate Presentation Q3 2020
PU
08/17BLUEBIRD BIO : to Present New Data from Clinical Studies of elivaldogene autotem..
BU
More most relevant news
All news about BLUEBIRD BIO, INC.
11/24BLUEBIRD BIO : Announces Live Webcast to Review Clinical Data Presented at the A..
BU
11/19BLUEBIRD BIO : Corporate Presentation - November 2020
PU
11/10SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
11/10BLUEBIRD BIO : Announces November Investor Events
BU
11/05BLUEBIRD BIO : to Present Data from Gene and Cell Therapy Programs During the 62..
BU
11/04BLUEBIRD : 3Q Earnings Snapshot
AQ
11/04BLUEBIRD BIO : Management's Discussion and Analysis of Financial Condition and R..
AQ
11/04BLUEBIRD BIO : Reports Third Quarter 2020 Financial Results and Highlights Opera..
BU
11/04BLUEBIRD BIO, INC. : Results of Operations and Financial Condition, Financial St..
AQ
10/02BLUEBIRD BIO, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
More news
News in other languages on BLUEBIRD BIO, INC.
02/26BLUEBIRD BIO, INC. : Veröffentlichung des Jahresergebnisses
02/26BLUEBIRD BIO, INC. : publication des résultats annuels
2018ORIGINAL-RESEARCH : Medigene AG (von EQUITS GmbH): Kaufen
2018ORIGINAL-RESEARCH : Medigene AG (von EQUITS GmbH): Kaufen
2018BLUEBIRD BIO : gibt im New England Journal of Medicine veröffentlichte Zwischend..
2017Wall Street finit en hausse avec les techs et l'énergie
2017Les valeurs à suivre à Wall Street
2017US-Pharmafirma Gilead kauft Krebsspezialisten für 12 Mrd Dollar
2017BLUEBIRD BIO : annonce la présentation de données préliminaires de l'étude de Ph..
2017BLUEBIRD BIO : gibt auf der Jahrestagung der European Hematology Association (EH..
Press releases
11/24BLUEBIRD BIO : Announces Live Webcast to Review Clinical Data Presented at the A..
BU
11/19BLUEBIRD BIO : Corporate Presentation - November 2020
PU
11/10SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investor..
PR
11/10BLUEBIRD BIO : Announces November Investor Events
BU
11/05BLUEBIRD BIO : to Present Data from Gene and Cell Therapy Programs During the 62..
BU
More press releases